Clinical Trial Update: Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating divalproex sodium for post-traumatic stress disorder has completed; no efficacy results are provided in the document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Divalproex Sodium (Depakote) (divalproex sodium)

Snippet

Sponsor: VA Office of Research and Development | Conditions: PTSD | Phase 3 | Status: COMPLETED